Announce Date | 08/06/2025 |
EPS Normalized Actual | $0.25 (Miss by $-0.02) |
EPS GAAP Actual | $0.25 (Miss by $-0.02) |
Revenue Actual | $1.58818B |
Revenue Surprise | Beat by $1588.18M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.18472 |
EPS GAAP Estimate | $0.18472 |
Revenue Estimate | $1.43253835B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.126 | 17.93 | 0.92752 | 1.19567 | 13 |
Dec 2028 | 1.104 | 18.29 | 0.92466 | 1.17592 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.1 | 0.1 | 1.58818B | 9.59% | 1588.18M |
FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 1.45017B | 11.93% | 1450.17M |
FQ4 2024 (Dec 2024) | 0.152 | 0.152 | 1.55028B | 100% | 1550.28M |
FQ3 2024 (Sep 2024) | -0.0305 | -0.0305 | 1.52269B | 23.98% | 1522.69M |
FQ2 2024 (Jun 2024) | 0.0123 | 0.0123 | 1.43585B | 28.9% | 1435.85M |
FQ1 2024 (Mar 2024) | -0.0785 | -0.0785 | 1.2772B | 21.66% | 1277.2M |
FQ4 2023 (Dec 2023) | 0 | 0 | -4.54E-5B | 2588183.7% | -0.05M |
FQ3 2023 (Sep 2023) | -0.0311 | -0.0311 | 1.15755B | 8.96% | 1157.55M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.18472
Consensus Revenue Estimates
1.43253835B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.46491 | -- | 0.43938 | 0.48536 | 8 |
FQ3 2027 (Sep 2027) | 0.32601 | -- | 0.29791 | 0.34493 | 5 |
FQ2 2027 (Jun 2027) | 0.39488 | -- | 0.36085 | 0.4178 | 5 |
FQ1 2027 (Mar 2027) | 0.38093 | -- | 0.36001 | 0.39768 | 8 |
FQ4 2026 (Oct 2026) | 0.3835 | -- | 0.31347 | 0.41717 | 7 |
FQ3 2026 (Jul 2026) | 0.32582 | -- | 0.26632 | 0.35443 | 4 |
FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 4 |
FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 4 |
FQ4 2025 (Oct 2025) | 0.25863 | 41.23 | 0.2114 | 0.28134 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.16B | -- | 2.07B | 2.23B | 10 |
FQ3 2027 (Sep 2027) | 1.98B | -- | 1.85B | 2.07B | 14 |
FQ2 2027 (Jun 2027) | 1.99B | -- | 1.86B | 2.08B | 9 |
FQ1 2027 (Mar 2027) | 2.03B | -- | 1.94B | 2.09B | 10 |
FQ4 2026 (Oct 2026) | 1.7B | -- | 1.46B | 1.81B | 14 |
FQ3 2026 (Jul 2026) | 1.64B | -- | 1.41B | 1.75B | 18 |
FQ2 2026 (Jun 2026) | 1.58B | -0.35 | 1.34B | 1.69B | 10 |
FQ1 2026 (Mar 2026) | 1.44B | -0.72 | 1.22B | 1.54B | 16 |
FQ4 2025 (Oct 2025) | 1.5B | -3.34 | 1.29B | 1.6B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.1 | 0.1 | 100% | |
FQ1 2025 (Mar 2025) | 0.01 | 0.01 | 100% | |
FQ4 2024 (Dec 2024) | 0.152 | 0.152 | 100% | |
FQ3 2024 (Sep 2024) | -0.0305 | -0.0305 | 100% | |
FQ2 2024 (Jun 2024) | 0.0123 | 0.0123 | 100% | |
FQ1 2024 (Mar 2024) | -0.0785 | -0.0785 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | -0.0311 | -0.0311 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $1.59B | $1588.18M | 100% |
FQ1 2025 (Mar 2025) | $0B | $1.45B | $1450.17M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.55B | $1550.28M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.52B | $1522.69M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.44B | $1435.85M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.28B | $1277.2M | 100% |
FQ4 2023 (Dec 2023) | $0B | $-0B | $-0.05M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.16B | $1157.55M | 100% |